Pfizer's $14B Medivation deal's now a cautionary M&A tale, thanks to ASCO: analyst http://www.fiercepharma.com/pharma/pfizer-s-14b-medivation-deal-s-now-a-cautionary-m-a-tale-thanks-to-asco-data-analyst